Two successfully completed pregnancies in adult onset Pompe disease, under continued treatment with alglucosidase alfa

被引：0
|
作者：
Julie Van Houtte
Jan L. De Bleecker
机构：
[1] Ghent University Hospital,Department of Neurology and Neuromuscular Reference Centre
来源：
Acta Neurologica Belgica | 2019年 / 119卷
关键词：
Pompe disease; Enzyme replacement therapy; Pregnancy; Myopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 149
页数：2
相关论文
共 50 条
  • [1] Two successfully completed pregnancies in adult onset Pompe disease, under continued treatment with alglucosidase alfa
    Van Houtte, Julie
    De Bleecker, Jan L.
    [J]. ACTA NEUROLOGICA BELGICA, 2019, 119 (01) : 147 - 149
  • [2] Severe sleep apnea associated with adult onset Pompe disease: Improvement with alglucosidase alfa
    Kiyan, E.
    Engin-Unver, R.
    Deymeer, F.
    Parman, Y.
    Serdaroglu-Oflazer, P.
    [J]. NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 593 - 594
  • [3] High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
    de Vries, Juna M.
    van der Beek, Nadine A. M. E.
    Kroos, Marian A.
    Ozkan, Lale
    van Doorn, Pieter A.
    Richards, Susan M.
    Sung, Crystal C. C.
    Brugma, Jan-Dietert C.
    Zandbergen, Adrienne A. M.
    van der Ploeg, Ans T.
    Reuser, Arnold J. J.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2010, 101 (04) : 338 - 345
  • [4] Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa
    Lipinski, Shawn E.
    Lipinski, Michael J.
    Burnette, Autumn
    Platts-Mills, Thomas A.
    Wilson, William G.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2009, 98 (03) : 319 - 321
  • [5] Pompe Disease Treatment success with Alglucosidase alfa in the late form of the disease
    Ecker-Schlipf, Barbara
    [J]. PSYCHOPHARMAKOTHERAPIE, 2010, 17 (05): : 255 - 256
  • [6] Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
    Benedikt Schoser
    [J]. BMC Musculoskeletal Disorders, 14 (Suppl 2)
  • [7] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    V. Gragnaniello
    S. Fecarotta
    A. Pecoraro
    A. Tarallo
    A. Catzola
    G. Spadaro
    G. Parenti
    R. Della Casa
    [J]. Neurological Sciences, 2019, 40 : 1453 - 1455
  • [8] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    Gragnaniello, V.
    Fecarotta, S.
    Pecoraro, A.
    Tarallo, A.
    Catzola, A.
    Spadaro, G.
    Parenti, G.
    Della Casa, R.
    [J]. NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1453 - 1455
  • [9] COMET: Safety of avalglucosidase alfa in patients with late-onset Pompe disease who switched treatment from alglucosidase alfa
    Diaz-Manera, J.
    Kishnani, P.
    Ladha, S.
    Miossec, P.
    Armstrong, N.
    Thibault, N.
    Periquet, M.
    Tammireddy, S.
    Dimachkie, M.
    Schoser, B.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S152 - S152
  • [10] A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
    van der Ploeg, Ans T.
    Clemens, Paula R.
    Corzo, Deyanira
    Escolar, Diana M.
    Florence, Julaine
    Groeneveld, Geert Jan
    Herson, Serge
    Kishnani, Priya S.
    Laforet, Pascal
    Lake, Stephen L.
    Lange, Dale J.
    Leshner, Robert T.
    Mayhew, Jill E.
    Morgan, Claire
    Nozaki, Kenkichi
    Park, Dorothy J.
    Pestronk, Alan
    Rosenbloom, Barry
    Skrinar, Alison
    van Capelle, Carine I.
    van der Beek, Nadine A.
    Wasserstein, Melissa
    Zivkovic, Sasa A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1396 - 1406
12345